Delivery Order SPE2DB20D1109-SPE2DB25FP15X
Award Date 5/30/25
Potential Completion Date 6/23/25
Potential Value $4.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,385.52 for ORGOVYX 120 mg tablets (30-count units) on July 24, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. ORGOVYX is a prescription medication used in the treatment of prostate cancer, reflecting DLA's ongoing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, with a contract ceiling value of $1,385.52. This firm fixed-price delivery order represents a non-set-aside competitive award with an ultimate completion date of August 20, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. ORGOVYX...
- The Defense Logistics Agency awarded a delivery order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of ORGOVYX 120 mg tablets (30-count units) on July 31, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award to the prime contractor and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ORGOVYX is a prescription medication used in the treatment...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of ORGOVYX 120 mg tablets (30-count units) valued at $2,771.04, with an ultimate completion date of October 3, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's Conshohocken, Pennsylvania location. ORGOVYX is a prescription medication used in the treatment of advanced prostate cancer,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $4,156.56 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. The contract is a firm fixed price, non-set-aside award with an ultimate completion date of August 27, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. ORGOVYX is a prescription medication used in the treatment of advanced prostate...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) on August 7, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a single pharmaceutical procurement from the vendor's corporate office located in Conshohocken, Pennsylvania. ORGOVYX is a prescription medication used in the treatment of...
- The Defense Logistics Agency awarded a $1,385.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 units of ORGOVYX 120 mg tablets, with an ultimate completion date of July 17, 2025. This non-set-aside contract was competitively awarded on June 25, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. ORGOVYX is a prescription medication used in the treatment of prostate cancer, representing the type of specialized pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) valued at $1,385.52, with completion scheduled for July 18, 2025. This competitive, non-set-aside contract utilizes firm fixed-price delivery order terms and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. ORGOVYX is a prescription medication used in the treatment of prostate cancer, reflecting the DLA's ongoing need...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $8,313.12 for ORGOVYX 120 mg tablets (30-count units) on September 2, 2025, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of ORGOVYX 120 mg tablets in packages of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,385.52, with an ultimate completion date of August 19, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...